Wikidata

(Q48384922)

English

JD-5006 and JD-5037: peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities.

scientific article published on 20 August 2012

In more languages

Statements

title
JD-5006 and JD-5037: peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22959249
retrieved
11 February 2018
reference URL
http://europepmc.org/abstract/MED/22959249
main subject
CNR2
0 references
cannabinoids
0 references
cannabinoid receptor
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q48384922&oldid=1067287197"